GUERINI ROCCO, ELENA
GUERINI ROCCO, ELENA
Dipartimento di Oncologia ed Emato-Oncologia
Mismatch repair (MMR) and microsatellite instability (MSI) phenotypes across solid tumors: A comprehensive cBioPortal study on prevalence and prognostic impact
2025 K. Venetis, C. Frascarelli, L.B. Bielo, G. Cursano, R. Adorisio, M. Ivanova, E. Mane, V. Peruzzo, A. Concardi, M. Negrelli, M. D'Ercole, F.M. Porta, Y. Zhan, A. Marra, D. Trapani, C. Criscitiello, G. Curigliano, E. Guerini-Rocco, N. Fusco
The Safety and Suitability of DNA Sequencing of Tissue Biopsies Performed on Patients Referred to a Phase I Unit
2024 A. Esposito, E. Crimini, C. Criscitiello, C. Belli, R. Scafetta, R. Scalia, G. Castellano, E. Giordano, J. Katrini, L. Ascione, L. Boscolo Bielo, M. Repetto, A. Marra, D. Trapani, G.M. Varano, D. Maiettini, P. Della Vigna, F. Orsi, E. Guerini Rocco, N. Fusco, G. Curigliano
Invasive lobular breast cancer: Focus on prevention, genetics, diagnosis, and treatment
2024 G. Corso, N. Fusco, E. Guerini-Rocco, M.C. Leonardi, C. Criscitiello, P. Zagami, E. Nicolo, G. Mazzarol, C. La Vecchia, F. Pesapane, C. Zanzottera, P. Tarantino, S. Petitto, B. Bianchi, G. Massari, A. Boato, A. Sibilio, A. Polizzi, G. Curigliano, A.M. De Scalzi, F. Lauria, B. Bonanni, M. Marabelli, A. Rotili, L. Nicosia, A. Albini, M. Calvello, R.A. Mukhtar, M.E. Robson, V. Sacchini, G. Rennert, V. Galimberti, P. Veronesi, F. Magnoni
PD-L1 testing in metastatic triple-negative breast cancer: Interobserver and interplatform reproducibility of CE-IVD assays for CPS and IC scores
2024 M. Ivanova, C. Frascarelli, B. Cerbelli, M.G. Pignataro, A. Pernazza, K. Venetis, E. Sajjadi, C. Criscitiello, G. Curigliano, E. Guerini-Rocco, P. Graziano, M. Martini, G. D'Amati, N. Fusco
Genomic and clinical landscape of metastatic hormone receptors-positive breast cancers carrying ESR1 alterations
2024 L. Boscolo Bielo, E. Guerini Rocco, D. Trapani, P. Zagami, B. Taurelli Salimbeni, A. Esposito, C. Belli, E. Crimini, K. Venetis, E. Munzone, N. Fusco, C. Criscitiello, A. Marra, G. Curigliano
Standardized pathology report for HER2 testing in compliance with 2023 ASCO/CAP updates and 2023 ESMO consensus statements on HER2-low breast cancer
2024 M. Ivanova, F.M. Porta, M. D'Ercole, C. Pescia, E. Sajjadi, G. Cursano, E. De Camilli, O. Pala, G. Mazzarol, K. Venetis, E. Guerini-Rocco, G. Curigliano, G. Viale, N. Fusco
PIK3CA testing in hormone receptor-positive/HER2-negative metastatic breast cancer: real-world data from Italian molecular pathology laboratories
2024 F. Pepe, K. Venetis, G. Cursano, C. Frascarelli, P. Pisapia, D. Vacirca, C. Scimone, A. Rappa, G. Russo, E. Mane, F. Pagni, I. Castellano, G. Troncone, C.D. Angelis, G. Curigliano, E. Guerini-Rocco, U. Malapelle, N. Fusco
Deep learning algorithm on H&E whole slide images to characterize TP53 alterations frequency and spatial distribution in breast cancer
2024 C. Frascarelli, K. Venetis, A. Marra, E. Mane, M. Ivanova, G. Cursano, F.M. Porta, A. Concardi, A.G.M. Ceol, A. Farina, C. Criscitiello, G. Curigliano, E. Guerini-Rocco, N. Fusco
The Evolving Role of Genomic Testing in Early Breast Cancer: Implications for Diagnosis, Prognosis, and Therapy
2024 K. Venetis, C. Pescia, G. Cursano, C. Frascarelli, E. Mane, E. De Camilli, E. Munzone, S. Dellapasqua, C. Criscitiello, G. Curigliano, E. Guerini Rocco, N. Fusco
Evaluation of the Geographical Accessibility of Genome-Matched Clinical Trials on a National Experience
2024 E. Crimini, G. Tini, P. Tarantino, L. Ascione, M. Repetto, P. Beria, A. Ranghiero, A. Marra, C. Belli, C. Criscitiello, A. Esposito, E. Guerini Rocco, M.C.P. Barberis, L. Mazzarella, G. Curigliano
Standardized molecular pathology workflow for ctDNA-based ESR1 testing in HR+/HER2- metastatic breast cancer
2024 E. Guerini-Rocco, K. Venetis, G. Cursano, E. Mane, C. Frascarelli, F. Pepe, M. Negrelli, E. Olmeda, D. Vacirca, A. Ranghiero, D. Trapani, C. Criscitiello, G. Curigliano, C. Rolfo, U. Malapelle, N. Fusco
A rationale for the poor response to alectinib in a patient with adenocarcinoma of the lung harbouring a STRN-ALK fusion by artificial intelligence and molecular modelling: a case report
2024 M. Barberis, A. Rappa, F. de Marinis, G. Pelosi, E.G. Rocco, Y. Zhan, G. Tiana
Concurrent presence of primary hemangioma and breast cancer metastasis within a lymph node: a case report inspired by the legacy of Professor Juan Rosai
2024 M. Ivanova, M. D'Ercole, F.M. Porta, B. Di Venosa, C. Frascarelli, C. Di Bella, F. Pagni, E. Guerini-Rocco, N. Fusco
Clinicopathological characteristics of multiple-classifier endometrial cancers: a cohort study and systematic review
2024 L. Antonio De Vitis, G. Schivardi, G. Caruso, C. Fumagalli, D. Vacirca, M. Teresa Achilarre, A. Aloisi, A. Garbi, V. Zanagnolo, G. Aletti, E. Guerini-Rocco, A. Mariani, A. Maggioni, M. Barberis, G. Bogani, N. Colombo, F. Multinu, I. Betella
CDH1 Genotype Exploration in Women With Hereditary Lobular Breast Cancer Phenotype
2024 G. Corso, E. Marino, C. Zanzottera, C. Oliveira, L. Bernard, D. Macis, J. Figueiredo, J. Pereira, P. Carneiro, G. Massari, M. Barberis, A.M. De Scalzi, S.V. Taormina, E. Sajjadi, C. Sangalli, S. Gandini, O. D'Ecclesiis, C.M. Trovato, A. Rotili, F. Pesapane, L. Nicosia, C. La Vecchia, V. Galimberti, E. Guerini-Rocco, B. Bonanni, P. Veronesi
Early Breast Cancer Risk Assessment: Integrating Histopathology with Artificial Intelligence
2024 M. Ivanova, C. Pescia, D. Trapani, K. Venetis, C. Frascarelli, E. Mane, G. Cursano, E. Sajjadi, C. Scatena, B. Cerbelli, G. D'Amati, F.M. Porta, E. Guerini-Rocco, C. Criscitiello, G. Curigliano, N. Fusco
ESR1 mutations in HR+/HER2-metastatic breast cancer: Enhancing the accuracy of ctDNA testing
2023 K. Venetis, F. Pepe, C. Pescia, G. Cursano, C. Criscitiello, C. Frascarelli, E. Mane, G. Russo, B. Taurelli Salimbeni, G. Troncone, E. Guerini Rocco, G. Curigliano, N. Fusco, U. Malapelle
The molecular landscape of breast mucoepidermoid carcinoma
2023 K. Venetis, E. Sajjadi, M. Ivanova, S. Andaloro, S. Pessina, C. Zanetti, A. Ranghiero, G. Citelli, C. Rossi, M. Lucioni, U. Malapelle, F. Pagni, M. Barberis, E. Guerini-Rocco, G. Viale, N. Fusco
Immune Biomarkers in Triple-Negative Breast Cancer: Improving the Predictivity of Current Testing Methods
2023 F.M. Porta, E. Sajjadi, K. Venetis, C. Frascarelli, G. Cursano, E. Guerini-Rocco, N. Fusco, M. Ivanova
Circulating tumour DNA testing in metastatic breast cancer: Integration with tissue testing
2023 A. Ranghiero, C. Frascarelli, G. Cursano, C. Pescia, M. Ivanova, D. Vacirca, A. Rappa, S.V. Taormina, M. Barberis, N. Fusco, E.G. Rocco, K. Venetis